Jade Biosciences, Inc. (JBIO)

NASDAQ: JBIO · Real-Time Price · USD
8.46
-0.19 (-2.21%)
May 12, 2025, 1:24 PM - Market open
-2.21%
Market Cap 265.75M
Revenue (ttm) n/a
Net Income (ttm) -93.96M
Shares Out 31.42M
EPS (ttm) -18.79
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Apr 29, 2025
Volume 82,072
Open 8.77
Previous Close 8.65
Day's Range 8.22 - 9.31
52-Week Range 8.52 - 884.98
Beta n/a
Analysts Buy
Price Target 17.00 (+100.97%)
Earnings Date May 20, 2025

About JBIO

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2024
Employees 30
Stock Exchange NASDAQ
Ticker Symbol JBIO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for JBIO stock is "Buy" and the 12-month stock price forecast is $17.0.

Price Target
$17.0
(100.97% upside)
Analyst Consensus: Buy
Stock Forecasts

News

There is no news available yet.